Colin Hill is a renowned figure in AI and precision medicine, with a successful history in developing and commercializing AI solutions for biopharmaceutical drug discovery and development. He is the co-founder and CEO of Aitia Bio, which launched the world’s first Virtual Patients in 2020 for Multiple Myeloma, Prostate Cancer, and Alzheimer’s Disease. Colin is also on the board of Centrexion Therapeutics, focusing on non-opioid, non-addictive drugs for chronic pain.
To learn more about Colin, click here.